[{"type": "title", "data": "OB Induction and Cervical Ripening with Prostaglandin (Module)"}, {"type": "category", "data": "Admit/Transfer/Discharge"}, {"type": "note", "data": "Refer to Society of Obstetricians and Gynaecologists of Canada (SOGC) Clinical Practice Guideline Induction of Labour", "value": ""}, {"type": "note", "data": "Refer to Algorithm for Inpatient Induction", "value": ""}, {"type": "category", "data": "Patient Care"}, {"type": "note", "data": "Pre Cervical Ripening Assessments", "value": ""}, {"type": "order", "data": "Vital Signs", "value": "checked"}, {"type": "sentence", "data": "q4h"}, {"type": "order", "data": "Fetal Non-Stress Test (NST) - Inpatient", "value": "checked"}, {"type": "sentence", "data": "Routine, Reason: Pre Cervical Ripening Assessment, once"}, {"type": "note", "data": "Mechanical Option", "value": ""}, {"type": "note", "data": "ABSOLUTE CONTRAINDICATION:  \n- Low lying placenta", "value": ""}, {"type": "note", "data": "RELATIVE CONTRAINDICATIONS:  \n- Antepartum Hemorrhage (APH)  \n- Rupture of Membranes (ROM)  \n- Infection", "value": ""}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "Prepare for #18 single balloon intracervical foley catheter to be introduced into intracervical canal under sterile technique by MD. Inflate bulb with 30 to 60 mL of water."}, {"type": "sentence", "data": "Prepare for #18 cervical ripening balloon intracervical foley catheter to be introduced into intracervical canal under sterile technique by MD. Inflate each bulb with less than or equal to 80 mL of water."}, {"type": "order", "data": "Electronic Fetal Monitoring", "value": ""}, {"type": "sentence", "data": "Continuous for 1 hour post intracervical foley catheter insertion"}, {"type": "note", "data": "Prostaglandin Option", "value": ""}, {"type": "order", "data": "Assess Uterine Contractions", "value": ""}, {"type": "sentence", "data": "Assess q15min for 1 hour post administration of prostaglandin"}, {"type": "order", "data": "Electronic Fetal Monitoring", "value": ""}, {"type": "sentence", "data": "Continuous for 1 hour post administration of prostaglandin"}, {"type": "category", "data": "Diet/Nutrition"}, {"type": "order", "data": "NPO", "value": "checked"}, {"type": "sentence", "data": "No Exceptions, For 1 hour post administration of prostaglandin or intracervical foley insertion"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "Prostaglandin should not be used in the setting of trial of labour after cesarean section in the third trimester with a live fetus (risk of uterine rupture)", "value": ""}, {"type": "order", "data": "dinoprostone vaginal 1 mg/2.5 mL gel", "value": ""}, {"type": "sentence", "data": "1 application, vaginal, q6h, PRN other (see comment), drug form: gel"}, {"type": "order", "data": "dinoprostone vaginal 2 mg/2.5 mL gel", "value": ""}, {"type": "sentence", "data": "1 application, vaginal, q6h, PRN other (see comment), drug form: gel"}, {"type": "order", "data": "dinoprostone vaginal 10 mg insert", "value": ""}, {"type": "sentence", "data": "10 mg, vaginal, q12h, drug form: insert"}, {"type": "sentence", "data": "10 mg, vaginal, q24h, drug form: insert"}, {"type": "order", "data": "miSOPROStol", "value": ""}, {"type": "sentence", "data": "50 mcg, PO, q4h, PRN other (see comment), drug form: tab"}, {"type": "order", "data": "miSOPROStol", "value": ""}, {"type": "sentence", "data": "25 mcg, vaginal, q4h, PRN other (see comment), drug form: tab"}, {"type": "order", "data": "nitroglycerin 0.4 mg/spray spray", "value": "checked"}, {"type": "sentence", "data": "1 spray, sublingual, as directed, PRN other (see comment), drug form: spray"}]
